Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding

doi:10.1016/S2468-1253(20)30270-3

Comment

. 2020 Dec;5(12):1028-1029.

doi: 10.1016/S2468-1253(20)30270-3. Epub 2020 Sep 30.

Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding

Gregory J Dore¹, Mark Danta², Gail V Matthews³

Affiliations

¹ Department of Infectious Diseases, Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia. Electronic address: gdore@kirby.unsw.edu.au.
² Department of Gastroenterology, St Vincent's Clinical School, Darlinghurst, NSW, Australia; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.
³ Department of Infectious Diseases, Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.

PMID: 33007227
DOI: 10.1016/S2468-1253(20)30270-3

Comment

Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding

Gregory J Dore et al. Lancet Gastroenterol Hepatol. 2020 Dec.

. 2020 Dec;5(12):1028-1029.

doi: 10.1016/S2468-1253(20)30270-3. Epub 2020 Sep 30.

Authors

Gregory J Dore¹, Mark Danta², Gail V Matthews³

Affiliations

¹ Department of Infectious Diseases, Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia. Electronic address: gdore@kirby.unsw.edu.au.
² Department of Gastroenterology, St Vincent's Clinical School, Darlinghurst, NSW, Australia; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.
³ Department of Infectious Diseases, Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.

PMID: 33007227
DOI: 10.1016/S2468-1253(20)30270-3

No abstract available

PubMed Disclaimer

Comment on

Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis.
Tseng CH, Hsu YC, Chen TH, Ji F, Chen IS, Tsai YN, Hai H, Thuy LTT, Hosaka T, Sezaki H, Borghi JA, Cheung R, Enomoto M, Nguyen MH. Tseng CH, et al. Lancet Gastroenterol Hepatol. 2020 Dec;5(12):1039-1052. doi: 10.1016/S2468-1253(20)30249-1. Epub 2020 Sep 30. Lancet Gastroenterol Hepatol. 2020. PMID: 33007228

Cited by

Perspectives on current controversial issues in the management of chronic HBV infection.
Liaw YF. Liaw YF. J Gastroenterol. 2022 Nov;57(11):828-837. doi: 10.1007/s00535-022-01918-z. Epub 2022 Sep 2. J Gastroenterol. 2022. PMID: 36053366 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding

Affiliations

Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical